Separating value and cost in Value-Based payment models
The cost of medication has long been a topic of debate. One key question is whether, high-priced medications truly provide value by reducing the disease burden and offering financial benefits in the long run. This ‘return on investment’ concept becomes especially critical in value-based payment contracts, where the focus often shifts towards controlling short-term spending rather than addressing… Read More »